{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T01:13:36Z","timestamp":1794014016123,"version":"4.8.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":43,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Spatial and temporal intratumoral heterogeneity (ITH) remains a major challenge in the diagnosis, prognosis, and treatment of breast cancer. Recent advances in single-cell and spatial omics technologies have enabled unprecedented resolution of subclonal architectures, evolutionary trajectories, and microenvironmental interactions. This systematic and conceptual review aimed to synthesize and integrate current evidence on spatiotemporal ITH in human breast cancer, bridging empirical data with mechanistic interpretation through high-resolution profiling platforms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a systematic review following PRISMA 2020 guidelines, searching three databases (PubMed, Scopus, and Web of Science) and screening 1037 records published between January 2018 and May 2025. 19 original studies were included based on predefined eligibility criteria targeting single-cell RNA sequencing (scRNA-seq), spatial transcriptomics, or multi-omics approaches applied to human breast tumor samples. Data extraction focused on study design, technologies used, subclonal dynamics, spatial\/temporal resolution, tumor\u2013immune interactions, and risk of bias.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The included studies analyzed over 400,000 single cells from diverse breast cancer subtypes, with a predominance of triple-negative breast cancer. Subclonal plasticity was a recurrent feature, often characterized by EMT (epithelial-to-mesenchymal transition) signatures, cell-cycle heterogeneity, and immune evasion. Spatial analyses revealed discrete ecological niches shaped by immune exclusion and stromal patterning, while temporal assessments uncovered therapy-driven clonal selection, metabolic reprogramming, and enhancer remodeling. Interclonal and tumor\u2013immune communication were consistently associated with poor prognosis or therapeutic resistance. Most studies were judged to have low or moderate risk of bias, with transparent reporting and accessible data pipelines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Single-cell and spatial omics studies provide critical insights into the evolutionary ecology of breast cancer. By conceptually integrating spatial, temporal, and microenvironmental dimensions, this review highlights convergent evolutionary programs underlying tumor aggressiveness and resistance. Spatiotemporal ITH is a key driver of disease progression, and its systematic characterization could inform biomarker development, personalized therapies, and future multi-modal diagnostics. Continued integration of spatial, temporal, and functional data is essential to move from descriptive maps to clinically actionable frameworks.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-026-15928-0","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T05:55:24Z","timestamp":1775454924000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Spatial and temporal intratumoral heterogeneity in breast cancer: a systematic and conceptual review of single-cell and spatial omics studies"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-2172-1058","authenticated-orcid":false,"given":"Imad","family":"Barjij","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oumaima","family":"Lamsyah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanae","family":"Kdadri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sihame","family":"Lkhoyaali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salma","family":"Najem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Naciri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanane","family":"Inrhaouen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Elghissassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saber","family":"Boutayeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hind","family":"Mrabti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Errihani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,6]]},"reference":[{"key":"15928_CR1","doi-asserted-by":"publisher","first-page":"107066","DOI":"10.1016\/j.compbiomed.2023.107066","volume":"161","author":"S Guo","year":"2023","unstructured":"Guo S, Liu X, Zhang J, Huang Z, Ye P, Shi J, et al. Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels T cell-related prognostic risk model and tumor immune microenvironment modulation in triple-negative breast cancer. Comput Biol Med. 2023;161:107066.","journal-title":"Comput Biol Med"},{"key":"15928_CR2","first-page":"465","volume":"14","author":"M Li","year":"2022","unstructured":"Li M, Yan T, Wang M, Cai Y, Wei Y. Advances in Single-Cell Sequencing Technology and Its Applications in Triple-Negative Breast Cancer. Breast Cancer: Targets Therapy. 2022;14:465\u201374.","journal-title":"Breast Cancer: Targets Therapy"},{"key":"15928_CR3","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1007\/s12094-023-03083-y","volume":"25","author":"J Qiu","year":"2023","unstructured":"Qiu J, Ma L, Wang T, Chen J, Wang D, Guo Y, et al. Bioinformatic analysis of single-cell RNA sequencing dataset dissects cellular heterogeneity of triple-negative breast cancer in transcriptional profile, splicing event and crosstalk network. Clin Transl Oncol. 2023;25:1856\u201368.","journal-title":"Clin Transl Oncol"},{"key":"15928_CR4","doi-asserted-by":"publisher","first-page":"5793","DOI":"10.3934\/mbe.2022271","volume":"19","author":"Y Shi","year":"2022","unstructured":"Shi Y, Huang X, Du Z, Tan J. Analysis of single-cell RNA-sequencing data identifies a hypoxic tumor subpopulation associated with poor prognosis in triple-negative breast cancer. Math Biosci Eng. 2022;19:5793\u2013812.","journal-title":"Math Biosci Eng"},{"key":"15928_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/genes14010044","author":"L Ji","year":"2022","unstructured":"Ji L, Wu J, Han J. Analysis of tumor microenvironment heterogeneity among breast cancer subtypes to identify subtype-specific signatures. Genes. 2022. https:\/\/doi.org\/10.3390\/genes14010044.","journal-title":"Genes"},{"key":"15928_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.643692","author":"X Yuan","year":"2021","unstructured":"Yuan X, Wang J, Huang Y, Shangguan D, Zhang P. Single-cell profiling to explore immunological heterogeneity of tumor microenvironment in breast cancer. Front Immunol. 2021. https:\/\/doi.org\/10.3389\/fimmu.2021.643692.","journal-title":"Front Immunol"},{"key":"15928_CR7","doi-asserted-by":"publisher","first-page":"107205","DOI":"10.1016\/j.phrs.2024.107205","volume":"204","author":"L Zhou","year":"2024","unstructured":"Zhou L, Yu C-W. Epigenetic modulations in triple-negative breast cancer: Therapeutic implications for tumor microenvironment. Pharmacol Res. 2024;204:107205.","journal-title":"Pharmacol Res"},{"key":"15928_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101582","author":"C Henon","year":"2024","unstructured":"Henon C, Vibert J, Eychenne T, Gruel N, Colmet-Daage L, Ngo C, et al. Single-cell multiomics profiling reveals heterogeneous transcriptional programs and microenvironment in DSRCTs. Cell Rep Med. 2024. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101582.","journal-title":"Cell Rep Med"},{"key":"15928_CR9","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s13046-021-01955-1","volume":"40","author":"L Li","year":"2021","unstructured":"Li L, Xiong F, Wang Y, Zhang S, Gong Z, Li X, et al. What are the applications of single-cell RNA sequencing in cancer research: A systematic review. J Experimental Clin Cancer Res. 2021;40:163.","journal-title":"J Experimental Clin Cancer Res"},{"key":"15928_CR10","doi-asserted-by":"publisher","first-page":"765578","DOI":"10.3389\/fcell.2021.765578","volume":"9","author":"R-Q Wang","year":"2021","unstructured":"Wang R-Q, Zhao W, Yang H-K, Dong J-M, Lin W-J, He F-Z, et al. Single-Cell RNA Sequencing Analysis of the Heterogeneity in Gene Regulatory Networks in Colorectal Cancer. Front Cell Dev Biology. 2021;9:765578.","journal-title":"Front Cell Dev Biology"},{"key":"15928_CR11","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s40364-024-00654-1","volume":"12","author":"X Xiong","year":"2024","unstructured":"Xiong X, Wang X, Liu C-C, Shao Z-M, Yu K-D. Deciphering breast cancer dynamics: Insights from single-cell and spatial profiling in the multi-omics era. Biomark Res. 2024;12:107.","journal-title":"Biomark Res"},{"key":"15928_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-04278-5","author":"S Sammut","year":"2022","unstructured":"Sammut S, Crispin-Ortuzar M, Chin S, Provenzano E, Bardwell H, Ma W, et al. Multi-omic machine learning predictor of breast cancer therapy response. Nature. 2022. https:\/\/doi.org\/10.1038\/s41586-021-04278-5.","journal-title":"Nature"},{"key":"15928_CR13","doi-asserted-by":"publisher","first-page":"100975","DOI":"10.1016\/j.jpha.2024.100975","volume":"14","author":"W Cheng","year":"2024","unstructured":"Cheng W, Mi W, Wang S, Wang X, Jiang H, Chen J, et al. Dissection of triple-negative breast cancer microenvironment and identification of potential therapeutic drugs using single-cell RNA sequencing analysis. J Pharm Anal. 2024;14:100975.","journal-title":"J Pharm Anal"},{"key":"15928_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cels.2020.07.004","author":"AE Davies","year":"2020","unstructured":"Davies AE, Pargett M, Siebert S, Gillies TE, Choi Y, Tobin SJ, et al. Systems-level properties of EGFR-RAS-ERK signaling amplify local signals to generate dynamic gene expression heterogeneity. Cell Syst. 2020. https:\/\/doi.org\/10.1016\/j.cels.2020.07.004.","journal-title":"Cell Syst"},{"key":"15928_CR15","doi-asserted-by":"publisher","DOI":"10.7150\/thno.96163","author":"Z Gao","year":"2024","unstructured":"Gao Z, Fang H, Sun S, Liu S, Fang Z, Liu Z, et al. Single-cell analyses reveal evolution mimicry during the specification of breast cancer subtype. Theranostics. 2024. https:\/\/doi.org\/10.7150\/thno.96163.","journal-title":"Theranostics"},{"key":"15928_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.557477","author":"K Jiang","year":"2021","unstructured":"Jiang K, Dong M, Li C, Sheng J. Unraveling heterogeneity of tumor cells and microenvironment and its clinical implications for triple negative breast cancer. Front Oncol. 2021. https:\/\/doi.org\/10.3389\/fonc.2021.557477.","journal-title":"Front Oncol"},{"key":"15928_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06052-0","author":"M Karaayvaz","year":"2018","unstructured":"Karaayvaz M, Cristea S, Gillespie S, Gillespie SM, Patel AP, Mylvaganam R, et al. Unravelling subclonal heterogeneity and aggressive disease states in TNBC through single-cell RNA-seq. Nat Commun. 2018. https:\/\/doi.org\/10.1038\/s41467-018-06052-0.","journal-title":"Nat Commun"},{"key":"15928_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241713053","author":"H Kim","year":"2023","unstructured":"Kim H, Wi\u015bniewska K, Regner MJ, Thennavan A, Spanheimer PM, Franco HL. Single-cell transcriptional and epigenetic profiles of male breast cancer nominate salient cancer-specific enhancers. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms241713053.","journal-title":"Int J Mol Sci"},{"key":"15928_CR19","doi-asserted-by":"publisher","first-page":"e0297260","DOI":"10.1371\/journal.pone.0297260","volume":"19","author":"W Gao","year":"2024","unstructured":"Gao W, Sun L, Gai J, Cao Y, Zhang S. Exploring the resistance mechanism of triple-negative breast cancer to paclitaxel through the scRNA-seq analysis. PLoS ONE. 2024;19:e0297260.","journal-title":"PLoS ONE"},{"key":"15928_CR20","doi-asserted-by":"publisher","DOI":"10.7150\/jca.95979","author":"Y Tzeng","year":"2024","unstructured":"Tzeng Y, Chu P, Yong S, Hsu T, Tseng L, Hou M, et al. Multi-omic profiling of breast tumor microenvironment uncovers a role of mitochondrial calcium gatekeepers. J Cancer. 2024. https:\/\/doi.org\/10.7150\/jca.95979.","journal-title":"J Cancer"},{"key":"15928_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04699-y","author":"Q Yuan","year":"2023","unstructured":"Yuan Q, Lu X, Guo H, Sun J, Yang M, Liu Q, et al. Low-density lipoprotein receptor promotes crosstalk between cell stemness and tumor immune microenvironment in breast cancer: A large data-based multi-omics study. J translational Med. 2023. https:\/\/doi.org\/10.1186\/s12967-023-04699-y.","journal-title":"J translational Med"},{"key":"15928_CR22","doi-asserted-by":"publisher","DOI":"10.1080\/15384101.2023.2281816","author":"Z Zhao","year":"2023","unstructured":"Zhao Z, Jin T, Chen B, Dong Q, Liu M, Guo J, et al. Multi-omics integration analysis unveils heterogeneity in breast cancer at the individual level. Cell cycle (Georgetown Tex). 2023. https:\/\/doi.org\/10.1080\/15384101.2023.2281816.","journal-title":"Cell cycle (Georgetown Tex)"},{"key":"15928_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.70273","author":"F Zhao","year":"2025","unstructured":"Zhao F, An R, Ma Y, Yu S, Gao Y, Wang Y, et al. Integrated spatial multi-omics profiling of Fusobacterium nucleatum in breast cancer unveils its role in tumour microenvironment modulation and cancer progression. Clin translational Med. 2025. https:\/\/doi.org\/10.1002\/ctm2.70273.","journal-title":"Clin translational Med"},{"key":"15928_CR24","doi-asserted-by":"crossref","unstructured":"Regner MJ, Garcia-Recio S, Thennavan A, Wisniewska K, Mendez-Giraldez R, Felsheim B, et al. Defining the Regulatory Logic of Breast Cancer Using Single-Cell Epigenetic and Transcriptome Profiling. 2024.","DOI":"10.1101\/2024.06.13.598858"},{"key":"15928_CR25","doi-asserted-by":"publisher","first-page":"110682","DOI":"10.1016\/j.isci.2024.110682","volume":"27","author":"H Song","year":"2024","unstructured":"Song H, Tang X, Liu M, Wang G, Yuan Y, Pang R, et al. Multi-omic analysis identifies metabolic biomarkers for the early detection of breast cancer and therapeutic response prediction. iScience. 2024;27:110682.","journal-title":"iScience"},{"key":"15928_CR26","doi-asserted-by":"publisher","first-page":"290","DOI":"10.31083\/j.fbl2908290","volume":"29","author":"H Zhang","year":"2024","unstructured":"Zhang H, Sun Y, Du X. Revealing Cellular Heterogeneity and Key Regulatory Factors of Triple-Negative Breast Cancer through Single-Cell RNA Sequencing. Front Bioscience-Landmark. 2024;29:290.","journal-title":"Front Bioscience-Landmark"},{"key":"15928_CR27","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.omtn.2020.12.018","volume":"23","author":"S Zhou","year":"2021","unstructured":"Zhou S, Huang Y, Liu H, Zhou X, Yuan M, Hou F, et al. Single-cell RNA-seq dissects the intratumoral heterogeneity of triple-negative breast cancer based on gene regulatory networks. Mol Therapy - Nucleic Acids. 2021;23:682\u201390.","journal-title":"Mol Therapy - Nucleic Acids"},{"key":"15928_CR28","doi-asserted-by":"publisher","first-page":"8353","DOI":"10.1038\/s41467-023-43458-x","volume":"14","author":"A Janesick","year":"2023","unstructured":"Janesick A, Shelansky R, Gottscho AD, et al. High resolution mapping of the tumor microenvironment using integrated single-cell, spatial and in situ analysis. Nat Commun. 2023;14:8353. https:\/\/doi.org\/10.1038\/s41467-023-43458-x.","journal-title":"Nat Commun"},{"key":"15928_CR29","doi-asserted-by":"publisher","first-page":"10232","DOI":"10.1038\/s41467-024-54145-w","volume":"15","author":"X Wang","year":"2024","unstructured":"Wang X, Venet D, Lifrange F, et al. Spatial transcriptomics reveals substantial heterogeneity in triple-negative breast cancer with potential clinical implications. Nat Commun. 2024;15:10232. https:\/\/doi.org\/10.1038\/s41467-024-54145-w.","journal-title":"Nat Commun"},{"key":"15928_CR30","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/s41588-021-00911-1","volume":"53","author":"SZ Wu","year":"2021","unstructured":"Wu SZ, Al-Eryani G, Roden DL, et al. A single-cell and spatially resolved atlas of human breast cancers. Nat Genet. 2021;53:1334\u201347. https:\/\/doi.org\/10.1038\/s41588-021-00911-1.","journal-title":"Nat Genet"},{"key":"15928_CR31","doi-asserted-by":"publisher","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, Savovi\u0107 J, Berkman ND, Viswanathan M, et al. ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919. https:\/\/doi.org\/10.1136\/bmj.i4919.","DOI":"10.1136\/bmj.i4919"},{"key":"15928_CR32","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1471-2288-14-43","volume":"14","author":"CR Hooijmans","year":"2014","unstructured":"Hooijmans CR, Rovers MM, Vries RBD, Leenaars M, Ritskes-Hoitinga M, Langendam MW. SYRCLE\u2019s risk of bias tool for animal studies. BMC Med Res Methodol. 2014;14:43.","journal-title":"BMC Med Res Methodol"},{"key":"15928_CR33","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/s13643-020-01490-8","volume":"9","author":"SM Eick","year":"2020","unstructured":"Eick SM, Goin DE, Chartres N, Lam J, Woodruff TJ. Assessing risk of bias in human environmental epidemiology studies using three tools: Different conclusions from different tools. Syst Reviews. 2020;9:249.","journal-title":"Syst Reviews"},{"key":"15928_CR34","doi-asserted-by":"publisher","first-page":"31","DOI":"10.4103\/sja.SJA_543_18","volume":"13","author":"S Cuschieri","year":"2019","unstructured":"Cuschieri S. The STROBE guidelines. Saudi J Anaesth. 2019;13:31.","journal-title":"Saudi J Anaesth"},{"key":"15928_CR35","doi-asserted-by":"publisher","first-page":"29585","DOI":"10.1038\/s41598-024-81383-1","volume":"14","author":"X Li","year":"2024","unstructured":"Li X. Deciphering cell to cell spatial relationship for pathology images using SpatialQPFs. Sci Rep. 2024;14:29585. https:\/\/doi.org\/10.1038\/s41598-024-81383-1.","journal-title":"Sci Rep"},{"key":"15928_CR36","doi-asserted-by":"publisher","unstructured":"Li X, et al. Entropy measures for quantifying complexity in digital pathology and spatial omics. iScience. 28(6);112765. https:\/\/doi.org\/10.1016\/j.isci.2025.112765.","DOI":"10.1016\/j.isci.2025.112765"},{"key":"15928_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1517679","author":"J Wang","year":"2024","unstructured":"Wang J, Zhao F, Zhang Q, Sun Z, Xiahou Z, Wang C, et al. Unveiling the NEFH+ malignant cell subtype: Insights from single-cell RNA sequencing in prostate cancer progression and tumor microenvironment interactions. Front Immunol. 2024. https:\/\/doi.org\/10.3389\/fimmu.2024.1517679.","journal-title":"Front Immunol"},{"key":"15928_CR38","doi-asserted-by":"crossref","unstructured":"Li G. WITHDRAWN: Analysis of heterogeneity in subpopulations of breast cancer using single-cell RNA sequencing. 2023.","DOI":"10.21203\/rs.3.rs-2812493\/v1"},{"key":"15928_CR39","doi-asserted-by":"publisher","first-page":"e13697","DOI":"10.1111\/cpr.13697","volume":"57","author":"J Xie","year":"2024","unstructured":"Xie J, Yang A, Liu Q, Deng X, Lv G, Ou X, et al. Single-cell RNA sequencing elucidated the landscape of breast cancer brain metastases and identified ILF2 as a potential therapeutic target. Cell Prolif. 2024;57:e13697.","journal-title":"Cell Prolif"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-15928-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15928-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15928-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T06:01:05Z","timestamp":1782367265000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-15928-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,6]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15928"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-15928-0","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,6]]},"assertion":[{"value":"27 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original article has been updated: Funding section has been updated from \u201cNo specific funding was received for the conduct, analysis, or writing of this systematic review. The entire work was independently undertaken by the authors.\u201d to \u201cThe article processing charge for this publication was supported by the Institut de Recherche sur le Cancer (IRC), Morocco. The funder had no role in the design of the study, data collection, analysis, interpretation, or writing of the manuscript.\u201d","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This work is based exclusively on published studies and did not involve any new research with human participants or animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"639"}}